Sagimet Biosciences Inc. (SGMT)

3.45

-0.26 (-7.13%)

At close: Mar 03, 2025, 3:59 PM

3.51

1.68%

After-hours: Mar 03, 2025, 05:31 PM EST

Sagimet Biosciences Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19
Net Income	-27.88M	-30.5M	-24.44M	-11.37M	-14.26M
Depreciation & Amortization	n/a	130K	134K	124K	1K
Stock-Based Compensation	4.99M	1.88M	1.9M	775K	2.99M
Other Working Capital	-1.1M	1.3M	-615K	436K	-633K
Other Non-Cash Items	98K	-85K	883K	104K	168K
Deferred Income Tax	n/a	n/a	n/a	n/a	-93K
Change in Working Capital	-978K	4.21M	-55K	75K	645K
Operating Cash Flow	-23.77M	-24.49M	-21.71M	-10.42M	-10.55M
Capital Expenditures	n/a	n/a	n/a	n/a	n/a
Acquisitions	n/a	n/a	n/a	20K	n/a
Purchase of Investments	-19.62M	-41.45M	n/a	n/a	n/a
Sales Maturities Of Investments	32.2M	9.44M	n/a	n/a	n/a
Other Investing Acitivies	n/a	-32.01M	n/a	20K	-27K
Investing Cash Flow	12.58M	-32.01M	n/a	20K	-27K
Debt Repayment	n/a	n/a	n/a	n/a	-3.36M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-3.51M	-73K	9.74M	68.89M	21.85M
Financial Cash Flow	86.17M	-73K	9.74M	68.89M	18.48M
Net Cash Flow	74.98M	-56.57M	-11.97M	58.49M	7.91M
Free Cash Flow	-23.77M	-24.49M	-21.71M	-10.42M	-10.55M